Altre lingue Genetic Signatures Limited

Azioni

GSS

AU000000GSS4

Tempo differito Australian S.E. Altri mercati azionari 08:10:06 16/07/2024			Variaz. 5gg	Var. 1 gen.
0,76 ^AUD	0,00%		+5,56%	+74,71%

04/06	Genetic Signatures Limited annuncia che la Food & Drug Administration statunitense ha autorizzato il kit Easyscreen? Gastrointestinal Parasite Detection Kit e Gs1 Automated Workflow per la commercializzazione e la vendita negli Stati Uniti.	CI
30/04	Genetic Signatures nomina un CEO ad interim	MT

Altre lingue

Sblocca tutte le notizie: sii il primo a essere informato e reagisci prima dei mercati!

Registrazione 100% gratuita

Genetic Signatures Limited Announces That the US Food & Drug Administration Has Cleared the Company's Easyscreen? Gastrointestinal Parasite Detection Kit and Gs1 Automated Workflow for Marketing and Sale in the US	04/06
Genetic Signatures Launches AU$30 Million Equity Raising	04/06
Genetic Signatures Obtains FDA Clearance for Gastrointestinal Parasite Detection Kit	04/06
Genetic Signatures Appoints CEO	04/06
Genetic Signatures Ceases Development of EasyScreen Essentials Respiratory Product for US Market; Shares Down 11%	27/05
Genetic Signatures Appoints Interim CEO	30/04
Genetic Signatures' Sales Drop in Fiscal Q3	28/04
Genetic Signatures Secures TGA Approval for Updated EasyScreen Respiratory Pathogen Detection Kit Sale in Australia	22/04
Genetic Signatures Limited Reports Earnings Results for the Half Year Ended December 31, 2023	21/02
Genetic Signatures Completes Rights Issue	24/01
Genetic Signatures Closes AU$8 Million Placement	29/12
Genetic Signatures to Raise AU$15.9 Million via Placement	26/12
Genetic Signatures Raises AU$16 Million From Share Sale	22/12
Genetic Signatures Secures AU$7 Million R&D Tax Incentive Rebate for Fiscal Year 2023	19/12
Genetic Signatures Limited Appoints Stephane Chatonsky as Director	04/12
Genetic Signatures Fiscal Q1 Sales Fall 64% Due to Performance Issue	30/10/23
Genetic Signatures Limited(ASX:GSS) dropped from S&P/ASX Emerging Companies Index	18/09/23
Genetic Signatures Submits 510(k) Application to the US FDA to Market Parasite Detection Kit in the US; Shares Jump 17%	04/09/23
Genetic Signatures Limited Reports Earnings Results for the Full Year Ended June 30, 2023	31/08/23
Genetic Signatures Appoints CFO/COO	16/06/23

Non ci sono risultati per questa ricerca

Tutte le notizie Raccomandazione analisti Eventi più importanti Insiders Resoconti Comunicati stampa Pubblicazioni ufficiali Altre lingue Idee di trading Articoli MarketScreener Analisi MarketScreener

Altre lingue Genetic Signatures Limited

Azioni

GSS

AU000000GSS4

Altre lingue

Filtri